Bone Morphogenetic Protein 7
Research News and Information

Sunday, November 22, 2009

Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications.

29 Sep 2009 To improve bone regeneration around orthopedic biomaterials, researchers have attempted to combine growth factors on and in implants. Equally as exciting, greater bone growth has been demonstrated around nanoscaled materials (like helical rosette ... Read more...

Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute.

29 Sep 2009 We tested the hypothesis that synthetic composites containing a high percentage of osteoconductive biominerals well-integrated with a hydrophilic polymer matrix can be engineered to provide both the structural and biochemical framework of a viable ... Read more...

BMP7 promotes proliferation of nephron progenitor cells via a JNK-dependent mechanism.

28 Sep 2009 The iterative formation of nephrons during embryonic development relies on continual replenishment of progenitor cells throughout nephrogenesis. Defining molecular mechanisms that maintain and regulate this progenitor pool is essential to ... Read more...

Latest indexed articles for 'Bone Morphogenetic Protein 7'

These are the very latest articles for this heading:

• Increased osteoblast functions in the presence of BMP-7 short peptides for nanostructured biomaterial applications. 29 Sep 2009
• Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute. 29 Sep 2009
• BMP7 promotes proliferation of nephron progenitor cells via a JNK-dependent mechanism. 28 Sep 2009
• Differential regulation of E-cadherin and alpha-smooth muscle actin by BMP 7 in human renal proximal tubule epithelial cells and its implication in renal fibrosis. 7 Sep 2009
• Analysis of bone matrix composition and trabecular microarchitecture of the femoral metaphysis in patients with osteonecrosis of the femoral head. 30 Aug 2009
• Mechanical stimulation alters tissue differentiation and molecular expression during bone healing. 30 Aug 2009
• Regulation of pre-otic brain development by the cephalic neural crest. 29 Aug 2009
• [Bone Morphogenic Protein-7 (BMP7) and the kidneys: insights into the future management of chronic kidney diseases] 23 Aug 2009
• BAT: a new target for human obesity? 30 Jul 2009
• Periodic knee injections of BMP-7 delay cartilage degeneration induced by excessive running in rats. 30 Jul 2009
• Bone morphogenetic protein 7 induces mesenchymal-to-epithelial transition in melanoma cells, leading to inhibition of metastasis. 28 Jul 2009
• Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. 14 Jul 2009
• Heme oxygenase-1 inducer hemin attenuates the progression of remnant kidney model. 7 Jul 2009
• [Use of mesenchymal stem cells from adult bone marrow for injured tissue repair] 3 Jul 2009
• Combination of transforming growth factor-beta2 and bone morphogenetic protein 7 enhances chondrogenesis from adipose tissue-derived mesenchymal stem cells. 29 Jun 2009
• Deletion of BMP7 affects the development of bones, teeth, and other ectodermal appendages of the orofacial complex. 13 Jun 2009
• BMP7 and SHH regulate Pax2 in mouse retinal astrocytes by relieving TLX repression. 4 Jun 2009
• BMP-7 as antagonist of organ fibrosis. 30 May 2009
• Connective tissue growth factor is a Smad2 regulated amplifier of transforming growth factor beta actions in hepatocytes--but without modulating bone morphogenetic protein 7 signaling. 30 May 2009
• Follistatin modulates a BMP autoregulatory loop to control the size and patterning of sensory domains in the developing tongue. 25 May 2009

See a longer list of these articles.

Technical information about 'Bone Morphogenetic Protein 7'

Definition: A bone morphogenetic protein that is widely expressed during EMBRYONIC DEVELOPMENT. It is both a potent osteogenic factor and a specific regulator of nephrogenesis.

Registry Number: 0

Descriptor UI: D055419

Alternative terms: Bone Morphogenetic Protein 7; Osteogenic Protein-1; Osteogenic Protein 1; BMP-7;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D12.644.276.954.200.700; D12.776.467.942.200.700; D23.529.942.200.700;

History Note: 2009(1990)